Floatz logo

249 assets in Head And Neck Squamous Cell Carcinoma

Therapeutic assets addressing Head And Neck Squamous Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Emunkitug
Head And Neck Squamous Cell Carcinoma
HiFiBiO TherapeuticsP1C (37)
Fpi-2053
Head And Neck Squamous Cell Carcinoma
AstraZenecaP1C (37)
ft836
Head And Neck Squamous Cell Carcinoma
Fate TherapeuticsP1C (37)
[Ga-68]-Pnt6555
Head And Neck Squamous Cell Carcinoma
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and CompanyP1C (37)
hh160
Head And Neck Squamous Cell Carcinoma
Huahui HealthP1C (37)
Hryz-T101
Head And Neck Squamous Cell Carcinoma
HRYZ Biotech Co.P1C (37)
Hryz-T101 Tcr-T Cell
Head And Neck Squamous Cell Carcinoma
HRYZ Biotech Co.P1C (37)
ide034
Head And Neck Squamous Cell Carcinoma
IDEAYA BiosciencesP1C (37)
il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells
Head And Neck Squamous Cell Carcinoma
Anusha KalbasiP1C (37)
Immunoglobulin G1, Anti-(Human Cc Chemokine Receptor Ccr8) (Human Monoclonal Chs114 ?1-Chain), Disulfide With Human Monoclonal Chs114 ?-Chain, Dimer
Head And Neck Squamous Cell Carcinoma
Coherus Oncology, Inc.P1C (37)
Immunoglobulin G1 [De-C-Terminal-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mus Musculus Clone Bca101 ?1-Chain), Disulfide With Human-Mus Musculus Clone Bca101 ?-Chain Fusion Protein With Peptide Linker (Ggggs)3 Fusion Protein With 23-159-Transforming Growth Factor ? Receptor Tgfbr2 (Human), Dimer
Head And Neck Squamous Cell Carcinoma
Bicara TherapeuticsP1C (37)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Tnfrsf4 (Tumor Necrosis Factor Receptor (Tnfr) Superfamily Member 4, Ox40, Cd134)], Homo Sapiens Monoclonal Antibody
Head And Neck Squamous Cell Carcinoma
HiFiBiO TherapeuticsP1C (37)
Itil-168
Head And Neck Squamous Cell Carcinoma
Instil BioP1C (37)
kj015
Head And Neck Squamous Cell Carcinoma
Shanghai Bao Pharmaceuticals Co., Ltd.P1C (37)
Lnth-2403
Head And Neck Squamous Cell Carcinoma
Radiopharm Theranostics, LtdP1C (37)
[Lu-177]-Pnt6555
Head And Neck Squamous Cell Carcinoma
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and CompanyP1C (37)
Lutetium [177Lu] Bl-Arc001
Head And Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P1C (37)
ly4052031
Head And Neck Squamous Cell Carcinoma
Eli Lilly and CompanyP1C (37)
ly4101174
Head And Neck Squamous Cell Carcinoma
Eli Lilly and CompanyP1C (37)
Modified Vaccinia Virus Ankara Vaccine Expressing P53
Head And Neck Squamous Cell Carcinoma
City of Hope Medical CenterP1C (37)
mq719
Head And Neck Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer CenterP1C (37)
Naptumomab Estafenatox
Head And Neck Squamous Cell Carcinoma
NeoTX Therapeutics Ltd.P1C (37)
Onm-501
Head And Neck Squamous Cell Carcinoma
OncoNano Medicine, Inc.P1C (37)
Pba-0405
Head And Neck Squamous Cell Carcinoma
Pure Biologics S.A.Early P1C (37)
pf-08046032
Head And Neck Squamous Cell Carcinoma
PfizerP1C (37)
P-Muc1C-Allo1 Car-T Cells
Head And Neck Squamous Cell Carcinoma
Poseida Therapeutics, Inc.P1C (37)
qls5316
Head And Neck Squamous Cell Carcinoma
Qilu Pharmaceutical Co., Ltd.P1C (37)
RC198
Head And Neck Squamous Cell Carcinoma
RemeGen Co., Ltd.P1C (37)
Rimiducid
Head And Neck Squamous Cell Carcinoma
Poseida Therapeutics, Inc.P1C (37)
Rph-075
Head And Neck Squamous Cell Carcinoma
R-PharmP1C (37)
sim0610 for
Head And Neck Squamous Cell Carcinoma
Jiangsu Simcere Pharmaceutical Co., Ltd.P1C (37)
Tbio-4101
Head And Neck Squamous Cell Carcinoma
Turnstone Biologics, Corp.P1C (37)
Telisotuzumab Adizutecan
Head And Neck Squamous Cell Carcinoma
AbbVieP1C (37)
Tilt-123
Head And Neck Squamous Cell Carcinoma
TILT Biotherapeutics Ltd.P1C (37)
vet3-tgi
Head And Neck Squamous Cell Carcinoma
KaliVir ImmunotherapeuticsP1C (37)
zm008
Head And Neck Squamous Cell Carcinoma
Zumutor Biologics Inc.P1C (37)
Fosifloxuridine Nafalbenamide
Head And Neck Squamous Cell Carcinoma
NuCana plcP1/2C (35)
89zr-dfo-n-suc-c9scfv
Head And Neck Squamous Cell Carcinoma
Var2 PharmaceuticalsEarly P1C (34)
89Zr-DFO-N-Suc-F8scFv
Head And Neck Squamous Cell Carcinoma
Var2 PharmaceuticalsEarly P1C (34)
Pba-0111
Head And Neck Squamous Cell Carcinoma
Pure Biologics S.A.Early P1C (34)
Milademetan
Head And Neck Squamous Cell Carcinoma
Rain Oncology IncP1/2C (33)
Sasanlimab
Head And Neck Squamous Cell Carcinoma
PfizerP1D (31)
afm24
Head And Neck Squamous Cell Carcinoma
NKGen Biotech, Inc.P1/2D (26)
Cabozantinib
Head And Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)P2NR ()
Decoy20
Head And Neck Squamous Cell Carcinoma
Indaptus Therapeutics, IncP1/2NR ()
dr-0202
Head And Neck Squamous Cell Carcinoma
Dren BioP1NR ()
Phase 1A: Lb-Lr1109
Head And Neck Squamous Cell Carcinoma
LG ChemP1NR ()
Volrustomig
Head And Neck Squamous Cell Carcinoma
AstraZenecaP2NR ()
Showing 201 to 249 of 249 assets
PreviousPage 5 of 5Next